eXoZymes Inc. (NASDAQ:EXOZ - Get Free Report) shares fell 4.8% on Thursday . The company traded as low as $9.31 and last traded at $9.31. 7,776 shares were traded during mid-day trading, an increase of 139% from the average session volume of 3,258 shares. The stock had previously closed at $9.78.
eXoZymes Price Performance
The company has a current ratio of 6.19, a quick ratio of 6.19 and a debt-to-equity ratio of 0.01. The business's fifty day simple moving average is $9.90.
eXoZymes (NASDAQ:EXOZ - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.28) earnings per share for the quarter.
About eXoZymes
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Featured Stories
Before you consider eXoZymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.
While eXoZymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
